These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11252789)
21. Vectors for recombinational cloning and gene expression in mammalian cells using modified vaccinia virus Ankara. Pradeau-Aubreton K; Ruff M; Garnier JM; Schultz P; Drillien R Anal Biochem; 2010 Sep; 404(1):103-5. PubMed ID: 20450873 [TBL] [Abstract][Full Text] [Related]
22. [Expression of beta-galactosidase in recombinant nonintegrated plasmids in evaluating the functional activity of vaccinia virus promoters]. Loparev VN; Chernos VI Mol Gen Mikrobiol Virusol; 1987 Nov; (11):34-9. PubMed ID: 3127696 [TBL] [Abstract][Full Text] [Related]
23. Assembly and analysis of a functional vaccinia virus "amplicon" containing the C-repeat region from the M protein of Streptococcus pyogenes. Hruby DE; Schneewind O; Wilson EM; Fischetti VA Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3190-4. PubMed ID: 2014239 [TBL] [Abstract][Full Text] [Related]
25. Recombinant expression of proteoglycans in mammalian cells. Utility and advantages of the vaccinia virus/T7 bacteriophage hybrid expression system. McQuillan DJ; Seo NS; Hocking AM; McQuillan CI Methods Mol Biol; 2001; 171():201-19. PubMed ID: 11450231 [No Abstract] [Full Text] [Related]
26. Requirements for optimal expression of secreted and nonsecreted recombinant proteins in vaccinia virus systems. Pfleiderer M; Falkner FG; Dorner F Protein Expr Purif; 1995 Oct; 6(5):559-69. PubMed ID: 8535147 [TBL] [Abstract][Full Text] [Related]
27. [Effective method of introducing plasmid DNA into eukaryotic cells by using liposomes for producing vaccinia virus recombinants]. Slepushkin VA; Bukrinskiĭ MI Biull Eksp Biol Med; 1987 Oct; 104(10):478-80. PubMed ID: 2823928 [TBL] [Abstract][Full Text] [Related]
28. High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara. Hebben M; Brants J; Birck C; Samama JP; Wasylyk B; Spehner D; Pradeau K; Domi A; Moss B; Schultz P; Drillien R Protein Expr Purif; 2007 Dec; 56(2):269-78. PubMed ID: 17892951 [TBL] [Abstract][Full Text] [Related]
29. Design and construction of recombinant vaccinia viruses. Broder CC; Earl PL Methods Mol Biol; 1997; 62():173-97. PubMed ID: 9108521 [No Abstract] [Full Text] [Related]
30. Dominant host range selection of vaccinia recombinants by rescue of an essential gene. Holzer GW; Gritschenberger W; Mayrhofer JA; Wieser V; Dorner F; Falkner FG Virology; 1998 Sep; 249(1):160-6. PubMed ID: 9740787 [TBL] [Abstract][Full Text] [Related]
31. Transient host range selection for genetic engineering of modified vaccinia virus Ankara. Staib C; Drexler I; Ohlmann M; Wintersperger S; Erfle V; Sutter G Biotechniques; 2000 Jun; 28(6):1137-42, 1144-6, 1148. PubMed ID: 10868279 [TBL] [Abstract][Full Text] [Related]
32. A rapid and simple method for determining the DNA sequences of fragments inserted into vaccinia virus. Sheng N; Zhang J; Whitton JL; McKee T Biotechniques; 1993 May; 14(5):781-4. PubMed ID: 8512703 [TBL] [Abstract][Full Text] [Related]
33. Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. Ward GA; Stover CK; Moss B; Fuerst TR Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6773-7. PubMed ID: 7624318 [TBL] [Abstract][Full Text] [Related]
34. Viable double vaccinia virus recombinants with the non-inducible phage T7 expression system. Kriajevska MV; Zakharova LG; Altstein AD J Gen Virol; 1993 Jan; 74 ( Pt 1)():47-53. PubMed ID: 8423450 [TBL] [Abstract][Full Text] [Related]
35. Expression and single-step purification of enzymatically active vaccinia virus thymidine kinase containing an engineered oligohistidine domain by immobilized metal affinity chromatography. Franke CA; Hruby DE Protein Expr Purif; 1993 Apr; 4(2):101-9. PubMed ID: 8471843 [TBL] [Abstract][Full Text] [Related]
36. Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants. Franke CA; Rice CM; Strauss JH; Hruby DE Mol Cell Biol; 1985 Aug; 5(8):1918-24. PubMed ID: 3018537 [TBL] [Abstract][Full Text] [Related]
37. Selection of recombinant vaccinia viruses on the basis of plaque formation. Blasco R; Moss B Gene; 1995 Jun; 158(2):157-62. PubMed ID: 7607536 [TBL] [Abstract][Full Text] [Related]
38. New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins. Davison AJ; Moss B Nucleic Acids Res; 1990 Jul; 18(14):4285-6. PubMed ID: 2377486 [No Abstract] [Full Text] [Related]
39. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. Abrams CC; King AM; Belsham GJ J Gen Virol; 1995 Dec; 76 ( Pt 12)():3089-98. PubMed ID: 8847514 [TBL] [Abstract][Full Text] [Related]
40. [Molecular-biological study of vaccinia virus genome. I. Cloning of vaccinia virus DNA fragments in bacterial vectors]. Riazankina OI; Totmenin AV; Shchelkunov SN; Malygin EG Mol Biol (Mosk); 1990; 24(4):962-7. PubMed ID: 2250684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]